T1	Participants 0 149	Safety and pharmacokinetics of a glycoPEGylated recombinant activated factorÂ VII derivative: a randomized first human dose trial in healthy subjects.
T2	Participants 1353 1362	including
T3	Participants 1751 1753	15
